The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Operating Cash Flow

Cash generated by the company's core business operations during the period.

The Oncology Institute, Inc.NASDAQ: TOI

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow dips below year-ago levels

Q1 FY2026 operating cash flow of $2.22M (cash outflow) fell 55.6% year over year, behind the +39.4% change in trailing-twelve-month operating cash flow. Over 3 fiscal years it compounded at -26.4% a year.

Context

  • Operating cash flow amounted to 4.9% of revenue in FY2025, down 1.9 pp from a year earlier.
  • Operating cash flow grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -55.6% toward the trailing-twelve-month pace of +39.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.22M-168.5% QoQ
Last fiscal yearDec 2025
-$24.59M-7.4% YoY
LTMMar 2026
-$21.81M+39.4% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-55.6%——
1 year-7.4%——
3-year CAGR-26.4%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
(24.59M) USD
Year-over-year change
+7.4%

Operating Cash Flow vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +39.4% is the 2nd highest of 10, against a peer median of -3.1%.
  • Operating cash flow amounts to 4.0% of revenue for TOI, versus a peer median of 6.2%.
TOI Competitors
Operating Cash Flow for TOI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUNAAuna S.A.LTM Mar 2026PEN 601.05M PEN-3.1%+14.3%13.3%
AUTLAutolus Therapeutics plcLTM Mar 2026$273.32M USD+13.3%+36.2%295.2%
AGLAgilon Health, Inc.LTM Mar 2026$50.05M USD+19.2%-6.8%0.9%
CBLLCeriBell, Inc.LTM Mar 2026$48.85M USD+32.4%+8.4%51.4%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$47.34M USD-60.5%-28.9%4.7%
EOLSEvolus, Inc.LTM Mar 2026$36.59M USD+59.0%-20.7%12.1%
TOIThe Oncology Institute, Inc.LTM Mar 2026$21.81M USD+39.4%-26.4%4.0%
SNDASonida Senior Living, Inc.LTM Mar 2026$15.35M USD-349.7%—3.7%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$12.93M USD-49.8%-19.5%6.2%
KIDSOrthoPediatrics Corp.LTM Mar 2026$3.98M USD-84.0%-39.4%1.6%
Peer median (excluding TOI) —-3.1%-13.2%6.2%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(10.93M)152K(83.07M)(53.01M)(60.61M)
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
Deferred Income Tax(1.24M)(263K)(76K)0(32K)
Stock-Based Compensation24.54M27.68M17.81M11.15M4.55M
Change in Working Capital(14.49M)(20.54M)2.36M18.06M1.33M
Accounts Receivables(2.99M)(19.67M)(4.5M)(5.77M)(12.58M)
Inventory(1.84M)(1.73M)(4.39M)3.64M(6.84M)
Accounts Payables2.92M(6.19M)5.06M9.22M19.64M
Other Working Capital(12.58M)7.04M6.19M10.98M1.11M
Other Non-Cash Items(33.9M)(73.2M)20.79M2.12M23.23M
Operating Cash Flow(32.68M)(61.76M)(36.32M)(26.54M)(24.59M)
Capital Expenditures(3.05M)(5.53M)(4.57M)(3.79M)(3.2M)
Acquisitions (Net)(9.11M)(8.58M)(4.46M)00
Purchases of Investments0(117.51M)(9.6M)00
Sales of Investments0081.26M50M126K
Other Investing Activities(200K)0000
Investing Cash Flow(12.15M)(131.61M)62.64M46.21M(3.07M)
Debt Repayment(7.25M)109.94M(101K)(39K)(20.04M)
Common Stock Issued00075K32.63M
Common Stock Repurchased0(9M)(1.02M)00
Dividends Paid00000
Other Financing Activities141.26M(8.74M)(5.73M)(3.53M)(1.04M)
Financing Cash Flow154.01M92.21M(6.85M)(3.49M)11.56M
Effect of Forex Changes00000
Net Change in Cash109.18M(101.16M)19.48M16.18M(16.1M)
Free Cash Flow(35.73M)(67.29M)(40.88M)(30.33M)(27.79M)

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.